Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of myRAteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A myRAteam Member asked a question 💭
Suffield, CT
January 20
 · 
Reactions
A myRAteam Member

A Vagus Nerve Stimulator device was installed in 2008 for the reason of my epilepsy. The settings were placed on this device in 2008 and remain unchanged. With all the above being said, the reading of the device is done by a neurological specialist when it is needed. My rheumatoid arthritis specialist is aware I have a VNS and the fact it is being used to maintain the health of my epilepsy.

January 30
myRAteam

Has anyone had success with a vagus nerve stimulator for rheumatoid arthritis?

The FDA recently approved the SetPoint System, an implantable vagus nerve stimulator specifically for moderate-to-severe RA. Clinical trial results showed promising outcomes:

At 3 months
- Participants had significantly greater improvement in Show Full Answer

Has anyone had success with a vagus nerve stimulator for rheumatoid arthritis?

The FDA recently approved the SetPoint System, an implantable vagus nerve stimulator specifically for moderate-to-severe RA. Clinical trial results showed promising outcomes:

At 3 months:
- Participants had significantly greater improvement in RA symptoms compared to those with a placebo device

At 12 months:
- Nearly half achieved low disease activity or remission
- 75% were able to stay off biologics or targeted synthetic DMARDs for a full year

Side effects:
- About 5% experienced hoarseness (most common)
- Just under 2% had serious side effects, mostly within the first three months
- Risks included pain or infection at the implant site

The device works by sending gentle electrical pulses to the vagus nerve once daily for 60 seconds. This helps regulate the body's immune response and reduce inflammation. It's designed for people who haven't responded well to biologics or JAK inhibitors, or who can't tolerate their side effects.

The implant is placed during an outpatient procedure through a small incision in the neck. SetPoint Medical plans to roll it out in select U.S. cities in 2025, with wider availability in 2026.

January 20

Related Questions

View All
A myRAteam Member asked a question 💭
Worcester, UK

A myRAteam Member asked a question 💭
Tulsa, OK